Synthesis and N-Methyl-D-aspartate (NMDA) Receptor Activity of Ketamine Metabolites

被引：65

作者：

Morris, Patrick J. ^{[1
]}

Moaddel, Ruin ^{[2
]}

Zanos, Panos ^{[3
]}

Moore, Curtis E. ^{[4
]}

Gould, Todd ^{[3
,5
,6
]}

Zarate, Carlos A., Jr. ^{[7
]}

Thomas, Craig J. ^{[1
]}

机构：

[1] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA

[2] NIA, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA

[3] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA

[4] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA

[5] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA

[6] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA

[7] NIMH, Expt Therapeut & Pathophysiol Branch, NIH, Bethesda, MD 20892 USA

来源：

ORGANIC LETTERS | 2017年 / 19卷 / 17期

关键词：

ANTIDEPRESSANT; MECHANISMS; DEPRESSION; AMINATION; CURRENTS; PLASMA;

D O I：

10.1021/acs.orglett.7b02177

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

Ketamine is rapidly metabolized in the human body to a variety of metabolites, including the hydroxynorketamines. At least two hydroxynorketamines have significant antidepressant action in rodent models, with limited action against the N-methyl-D-aspartate (NMDA) receptor. The synthesis of 12 hydroxynorketamines and their binding affinity to the NMDA receptor is presented here.

引用

页码：4572 / 4575

页数：4

共 23 条

[1] Berman F W, 1996, J Biochem Toxicol, V11, P217, DOI 10.1002/(SICI)1522-7146(1996)11:5<217::AID-JBT2>3.0.CO
[2] 2-N
[3] Asymmetric synthesis of (S)- and (R)-norketamine via Sharpless asymmetric dihydroxylation/Ritter amination sequence
Biermann, Manfred
Zheng, Guangrong
Hojahmat, Marhaba
Moskalev, Nick V.
Crooks, Peter A.
[J]. TETRAHEDRON LETTERS, 2015, 56 (20) : 2608 - 2610
[4] The use of ketamine as an antidepressant: a systematic review and meta-analysis
Coyle, Caoimhe M.
Laws, Keith R.
[J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2015, 30 (03) : 152 - 163
[5] Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs
Dale, Elena
Bang-Andersen, Benny
Sanchez, Connie
[J]. BIOCHEMICAL PHARMACOLOGY, 2015, 95 (02) : 81 - 97
[6] MOLECULAR DESIGN OF THE N-METHYL-D-ASPARTATE RECEPTOR-BINDING SITE FOR PHENCYCLIDINE AND DIZOLCIPINE
FERRERMONTIEL, AV
SUN, W
MONTAL, M
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) : 8021 - 8025
[7] STEREOCHEMICAL STUDIES OF DEMETHYLATED KETAMINE ENANTIOMERS
HONG, SC
DAVISSON, JN
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (08) : 912 - 914
[8] COMPARATIVE PHARMACOLOGY IN THE RAT OF KETAMINE AND ITS 2 PRINCIPAL METABOLITES, NORKETAMINE AND (Z)-6-HYDROXYNORKETAMINE
LEUNG, LY
BAILLIE, TA
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (11) : 2396 - 2399
[9] Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors
Moaddel, Ruin
Abdrakhmanova, Galia
Kozak, Joanna
Jozwiak, Krzysztof
Toll, Lawrence
Jimenez, Lucita
Rosenberg, Avraham
Tran, Thao
Xiao, Yingxian
Zarate, Carlos A.
Wainer, Irving W.
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 698 (1-3) : 228 - 234
[10] A parallel chiral-achiral liquid chromatographic method for the determination of the stereoisomers of ketamine and ketamine metabolites in the plasma and urine of patients with complex regional pain syndrome
Moaddel, Ruin
Venkata, Swarajya Lakshmi Vattem
Tanga, Mary J.
Bupp, James E.
Green, Carol E.
Iyer, Lalitha
Furimsky, Anna
Goldberg, Michael E.
Torjman, Marc C.
Wainer, Irving W.
[J]. TALANTA, 2010, 82 (05) : 1892 - 1904

← 1 2 3 →